Mellman I, Coukos G, Dranoff G. Cancer immunotherapy comes of age. Nature. 2011;480:480–9.
Article CAS PubMed PubMed Central Google Scholar
Ventola CL. Cancer immunotherapy, part 3: challenges and future trends. Pharm Ther. 2017;42:514–21.
Mulvaney P. Nanoscience versus nanotechnology: defining the field. ACS Nano. 2015;9:2215–7.
Article CAS PubMed Google Scholar
Zielińska A, Carreiró F, Oliveira AM, Neves A, Pires B, Venkatesh DN, et al. Polymeric nanoparticles: production, characterization, toxicology and ecotoxicology. Molecules. 2020;25:3731.
Article PubMed PubMed Central Google Scholar
Song B, Zhang Y, Liu J, Feng X, Zhou T, Shao L. Is neurotoxicity of metallic nanoparticles the cascades of oxidative stress? Nanoscale Res Lett. 2016;11:291.
Article PubMed PubMed Central Google Scholar
Gao G, Ze Y, Zhao X, Sang X, Zheng L, Ze X, et al. Titanium dioxide nanoparticle-induced testicular damage, spermatogenesis suppression, and gene expression alterations in male mice. J Hazard Mater. 2013;258–259:133–43.
Sundarraj K, Manickam V, Raghunath A, Periyasamy M, Viswanathan MP, Perumal E. Repeated exposure to iron oxide nanoparticles causes testicular toxicity in mice. Environ Toxicol. 2017;32:594–608.
Article CAS PubMed Google Scholar
Joudeh N, Linke D. Nanoparticle classification, physicochemical properties, characterization, and applications: a comprehensive review for biologists. J Nanobiotechnol. 2022;20:262.
Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R. Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov. 2021;20:101–24.
Article CAS PubMed Google Scholar
Zhang Z, Yao S, Hu Y, Zhao X, Lee RJ. Application of lipid-based nanoparticles in cancer immunotherapy. Front Immunol. 2022;13:967505.
Article CAS PubMed PubMed Central Google Scholar
Tenchov R, Bird R, Curtze AE, Zhou Q. Lipid nanoparticles: from liposomes to mRNA vaccine delivery, a landscape of research diversity and advancement. ACS Nano. 2021;15:16982–7015.
Article CAS PubMed Google Scholar
Mukherjee S, Ray S, Thakur RS. Solid lipid nanoparticles: a modern formulation approach in drug delivery system. Indian J Pharm Sci. 2009;71:349–58.
Article CAS PubMed PubMed Central Google Scholar
Xu L, Wang X, Liu Y, Yang G, Falconer RJ, Zhao CX. Lipid nanoparticles for drug delivery. Adv NanoBiomed Res. 2022;2:2100109.
Rajpoot K. Solid lipid nanoparticles: a promising nanomaterial in drug delivery. Curr Pharm Des. 2019;25:3943–59.
Article CAS PubMed Google Scholar
Thi TTH, Suys EJA, Lee JS, Nguyen DH, Park KD, Truong NP. Lipid-based nanoparticles in the clinic and clinical trials: from cancer nanomedicine to COVID-19 vaccines. Vaccines (Basel). 2021;9:359.
Article CAS PubMed Google Scholar
Dong Y, Siegwart DJ, Anderson DG. Strategies, design, and chemistry in siRNA delivery systems. Adv Drug Deliv Rev. 2019;144:133–47.
Article CAS PubMed PubMed Central Google Scholar
Barenholz Y. Doxil®: the first FDA-approved nano-drug: lessons learned. J Control Release. 2012;160:117–34.
Article CAS PubMed Google Scholar
Meyers PA. Muramyl tripeptide (mifamurtide) for the treatment of osteosarcoma. Expert Rev Anticancer Ther. 2009;9:1035–49.
Article CAS PubMed Google Scholar
Zong Y, Lin Y, Wei T, Cheng Q. Lipid nanoparticle (LNP) enables mRNA delivery for cancer therapy. Adv Mater. 2023;35:e2303261.
Suhaimi NAA, Ahmad S, Husna SMN, Sarmiento ME, Acosta A, Norazmi MN, et al. Application of liposomes in the treatment of infectious diseases. Life Sci. 2022;305:120734.
Article CAS PubMed Google Scholar
Chaudhary N, Weissman D, Whitehead KA. mRNA vaccines for infectious diseases: principles, delivery and clinical translation. Nat Rev Drug Discov. 2021;20:817–38.
Article CAS PubMed PubMed Central Google Scholar
Almenara-Fuentes L, Rodriguez-Fernandez S, Rosell-Mases E, Kachler K, You A, Salvado M, et al. A new platform for autoimmune diseases. Inducing tolerance with liposomes encapsulating autoantigens. Nanomedicine. 2023;48:102635.
Article CAS PubMed Google Scholar
Wang T, Suita Y, Miriyala S, Dean J, Tapinos N, Shen J. Advances in lipid-based nanoparticles for cancer chemoimmunotherapy. Pharmaceutics. 2021;13:520.
Article CAS PubMed PubMed Central Google Scholar
Bhardwaj P, Bhatia E, Sharma S, Ahamad N, Banerjee R. Advancements in prophylactic and therapeutic nanovaccines. Acta Biomater. 2020;108:1–21.
Article CAS PubMed PubMed Central Google Scholar
Huang T, Peng L, Han Y, Wang D, He X, Wang J, et al. Lipid nanoparticle-based mRNA vaccines in cancers: current advances and future prospects. Front Immunol. 2022;13:922301.
Article CAS PubMed PubMed Central Google Scholar
Liang J, Zhao X. Nanomaterial-based delivery vehicles for therapeutic cancer vaccine development. Cancer Biol Med. 2021;18:352–71.
Article CAS PubMed PubMed Central Google Scholar
Heuts J, Jiskoot W, Ossendorp F, Van Der Maaden K. Cationic nanoparticle-based cancer vaccines. Pharmaceutics. 2021;13:596.
Article CAS PubMed PubMed Central Google Scholar
Liu J, Miao L, Sui J, Hao Y, Huang G. Nanoparticle cancer vaccines: design considerations and recent advances. Asian J Pharm Sci. 2020;15:576–90.
Shaw I, Boafo GF, Ali YS, Liu Y, Mlambo R, Tan S, et al. Advancements and prospects of lipid-based nanoparticles: dual frontiers in cancer treatment and vaccine development. J Microencapsul. 2024;41:226–54.
Article CAS PubMed Google Scholar
Cheng Z, Li M, Dey R, Chen Y. Nanomaterials for cancer therapy: current progress and perspectives. J Hematol Oncol. 2021;14:85.
Article PubMed PubMed Central Google Scholar
Nel AE, Mei KC, Liao YP, Liu X. Multifunctional lipid bilayer nanocarriers for cancer immunotherapy in heterogeneous tumor microenvironments, combining immunogenic cell death stimuli with immune modulatory drugs. ACS Nano. 2022;16:5184–232.
留言 (0)